Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMAG

AMAG Pharmaceuticals (AMAG) Stock Price, News & Analysis

AMAG Pharmaceuticals logo

About AMAG Pharmaceuticals Stock (NASDAQ:AMAG)

Advanced Chart

Key Stats

Today's Range
$13.75
$13.75
50-Day Range
$13.69
$13.75
52-Week Range
$4.41
$13.80
Volume
N/A
Average Volume
950,664 shs
Market Capitalization
$477.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMAG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AMAG Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AMAG Stock News Headlines

AMAG Pharmaceuticals, Inc. (AMU.DE)
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer
KalVista Appoints Brian Piekos as Chief Financial Officer
See More Headlines

AMAG Stock Analysis - Frequently Asked Questions

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) released its earnings results on Monday, May, 11th. The specialty pharmaceutical company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by $0.27. The specialty pharmaceutical company earned $68.66 million during the quarter, compared to analysts' expectations of $64.95 million. AMAG Pharmaceuticals had a negative trailing twelve-month return on equity of 16.92% and a negative net margin of 74.93%.

Based on aggregate information from My MarketBeat watchlists, some other companies that AMAG Pharmaceuticals investors own include Bristol Myers Squibb (BMY), Palatin Technologies (PTN), Gilead Sciences (GILD), Meta Platforms (META), Bausch Health Cos (BHC), Netflix (NFLX) and Tesla (TSLA).

Company Calendar

Last Earnings
5/11/2020
Today
7/04/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:AMAG
Fax
N/A
Employees
440
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$466.46 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$327.75 million
Price / Cash Flow
N/A
Book Value
$7.37 per share
Price / Book
1.87

Miscellaneous

Free Float
N/A
Market Cap
$477.47 million
Optionable
Optionable
Beta
0.89
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:AMAG) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners